Cardiometabolic Risk Factors and Preclinical Target Organ Damage Among Adults in Ghana: Findings From a National Study.
Jie Li,Isaac Kofi Owusu,Qingshan Geng,Aba Ankomaba Folson,Zhichao Zheng,Yaw Adu‐Boakye,Xinran Dong,Wen‐Chih Wu,Francis Agyekum,Hongwen Fei,Harold Ayetey,Mulan Deng,Fred Adomako‐Boateng,Zuxun Jiang,Braimah Baba Abubakari,Zhao Xian,Forster Nketiah Fokuoh,Lambert Tetteh Appiah,Simin Liu,Chunying Lin
DOI: https://doi.org/10.1161/jaha.120.017492
IF: 6.106
2020-12-09
Journal of the American Heart Association
Abstract:Background Although sub‐Saharan Africa has a high prevalence of cardiovascular diseases (CVDs), there remains a lack of systematic and comprehensive assessment of risk factors and early CVD outcomes in adults in sub‐Saharan Africa. Methods and Results Using a stratified multistage random sampling method, we recruited 1106 men and women, aged >18 years, from the general population in Ghana to participate in a national health survey from 2016 to 2017. In Ghanaian adults, the age‐standardized prevalence of known CVD risk factors was 15.1% (95% CI, 12.9%–17.3%) for obesity, 6.8% (95% CI, 5.1%–8.5%) for diabetes mellitus, 26.1% (95% CI, 22.9%–29.4%) for hypertension, and 9.3% (95% CI, 7.1%–11.5%) for hyperuricemia. In addition, 10.1% (95% CI, 7.0%–13.2%) of adults had peripheral artery disease, 8.3% (95% CI, 6.7%–10.0%) had carotid thickening, 4.1% (95% CI, 2.9%–5.2%) had left ventricular hypertrophy, and 2.5% (95% CI, 1.5%–3.4%) had chronic kidney disease. Three CVD risk factors appeared to play prominent roles in the development of target organ damage, including obesity for peripheral artery disease (odds ratio [OR], 2.22; 95% CI, 1.35–3.63), hypertension for carotid thickening (OR, 1.92; 95% CI, 1.22–3.08), and left ventricular hypertrophy (OR, 5.28; 95% CI, 2.55–12.11) and hyperuricemia for chronic kidney disease (OR, 5.49; 95% CI, 2.84–10.65). Conclusions This comprehensive health survey characterized the baseline conditions of a national cohort of adults while confirming the prevalence of CVD risk factors, and early CVD outcomes have reached epidemic proportions in Ghana. The distinct patterns of risk factors in the development of target organ damage present important challenges and opportunities for interventions to improve cardiometabolic health among adults in Ghana. Nonstandard Abbreviations and Acronyms DBP diastolic blood pressure GBD Global Burden Disease GHS Ghana Heart Study LVM left ventricular mass SSA sub‐Saharan Africa TC total cholesterol TOD target organ damage Clinical Perspective What Is New? Cardiometabolic risk factors previously identified in populations of the developed countries are now common among adults in Ghana. However, there are regional‐ and sex‐specific patterns of risk factors in Ghana that are different from populations in the West. Obesity, hypertension, and hyperuricemia appear to play the most prominent roles in the early stage of cardiovascular disease development among Ghanaian adults. What Are the Clinical Implications? Prevention strategies targeting the risk factors with the strongest association with early cardiovascular disease outcomes may reduce the cardiovascular disease burden in Ghana. As globalization is accelerating the epidemiologic transition in different countries and shifting much of the cardiovascular disease burden to low‐ and middle‐income countries, disparities in health outcomes are expected to affect populations in low‐ and middle‐income countries, particularly in sub‐Saharan Africa. Findings from this national survey will establish a national cohort with continued follow‐up to ascertain clinical outcomes and guide the development of specific prevention and intervention strategies to improve cardiometabolic health outcomes among populations in sub‐Saharan Africa. Globally, cardiovascular diseases (CVDs) remain the leading cause of death. However, the CVD burden has not changed uniformly across world regions of different socioeconomic characteristics. Over the past decades, CVD mortality has dramatically declined in high‐income countries, whereas it has increased in low‐ and middle‐income countries. 1 According to the GBD (Global Burden Disease) study in 2015, the age‐standardized CVD prevalence is 6304 per 100 000 globally, with the highest rate in western sub‐Saharan Africa (SSA) (9475 per 1 -Abstract Truncated-
cardiac & cardiovascular systems